Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McClellan to lead empowered FDA

This article was originally published in The Gray Sheet

Executive Summary

Passage of the medical device user fee act, the bioterrorism bill and the reauthorization of prescription drug user fees in the 107th Congress "represent the most substantial expansion of the agency in more than a generation," the incoming FDA commissioner says Nov. 6 at the Schwab Washington Research Group annual symposium in Washington, D.C. "We'll have the opportunity and resources to achieve new levels of improvement in getting safe and effective treatments to market," McClellan said on assuming his new responsibilities Nov. 8...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT017454

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel